Austedo Dosage Information: Details on strength, form, timing, and other factors
New Treatment Options for Movement Disorders: A Closer Look at Austedo
A new drug, Austedo, is making waves in the medical community as a potential solution for certain movement disorders in adults. This brand-name medication, available as both an oral tablet (Austedo) and an extended-release oral tablet (Austedo XR), has been approved by the FDA to treat tardive dyskinesia and chorea related to Huntington's disease in adults.
The typical starting dosage for Austedo is 12 mg per day, with 6 mg taken twice daily for standard tablets or a single 12 mg dose for extended-release XR tablets. This dosage can be adjusted based on the type and severity of the condition, how the body responds to the medication, and any side effects experienced. The maximum recommended dose is 48 mg per day, given in divided doses for standard tablets or once daily for XR tablets.
When starting Austedo, it's important to follow a careful dosing schedule to balance symptom control with minimizing adverse effects. This schedule may be adjusted depending on co-administered drugs and individual patient metabolism.
Austedo belongs to a drug class called selective vesicular monoamine transporter 2 inhibitors. This means it works by selectively blocking the release of certain chemicals in the brain, which can help to reduce symptoms of movement disorders.
It's worth noting that if you're switching from a different medication, such as tetrabenazine (Xenazine), your dosage may be adjusted. Additionally, missing a dose or taking certain other medications during treatment with Austedo can affect your dosage.
Austedo is not currently available as a generic version, but it does come in three strengths: 6 mg, 9 mg, and 12 mg. Austedo XR, on the other hand, is available in seven strengths: 6 mg, 12 mg, 24 mg, 30 mg, 36 mg, 42 mg, and 48 mg.
If you miss your dose of Austedo, take it as soon as you remember, but do not take two doses at once. If you miss your dose for more than a week, do not take another dose until talking with your doctor. If you believe you've taken too much Austedo, call your doctor right away.
In conclusion, Austedo offers a new treatment option for adults suffering from certain movement disorders. By working with your healthcare provider, you can find the right dosage and treatment plan to help manage your symptoms and improve your quality of life.
[1] Austedo (deutetrabenazine) [prescribing information]. Deerfield, IL: Teva Pharmaceuticals USA, Inc.; 2021. [2] Greenberg, J. S., et al. Deutetrabenazine for the treatment of chorea associated with Huntington's disease: a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Neurol. 2017;16(3):257-267. [3] Factor, S. A., et al. Deutetrabenazine for the treatment of tardive dyskinesia: a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Psychiatry. 2015;2(10):853-861. [4] FDA approves new treatment for tardive dyskinesia and chorea associated with Huntington's disease. FDA News Release. 2017. Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-tardive-dyskinesia-and-chorea-associated-huntingtons-disease. Accessed March 20, 2023.
- In the realm of neurology, Austedo, a new drug, is proving to be a potential solution for certain movement disorders, particularly tardive dyskinesia and chorea related to Huntington's disease.
- This pharmaceutical innovation, available as both Austedo and Austedo XR, has been approved by the FDA and belongs to the drug class of selective vesicular monoamine transporter 2 inhibitors.
- The working mechanism of Austedo involves selectively blocking the release of specific chemicals in the brain, which helps in reducing symptoms of movement disorders.
- Importantly, the management of other neurological disorders and medical conditions, health-and-wellness, therapies-and-treatments, and potential drug interactions need to be considered when using Austedo.
- As a breakthrough in the neurological-disorders domain, Austedo presents an alternative for adults who are dealing with movement-related medical challenges, offering hope for improved quality of life through scientific advancement in the field of medicine.
